Ampio Pharmaceuticals, Inc.
DelistedCIK 1411906fmd_05RTPTW8757C2TGQHJ0PAMWP6YManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2023, 56 periods
Latest annual · FY2023
Millions- Net income
- (9)
- Free cash flow
- (21)
Latest quarter · Q4 FY2023
Millions- Net income
- (2)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2018 to FY2023
- n/m
Ampio Pharmaceuticals, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Net income | -$8.6 million | -$16.3 million | 10-K 2024-03-27 · proof | |
| Cash from operating activities | -$8.6 million | -$21.1 million | 10-K 2024-03-27 · proof | |
| Total assets | $5.7 million | $13.6 million | -57.8% | 10-K 2024-03-27 · proof |
| Total liabilities | $2.4 million | $1.8 million | +32.1% | 10-K 2024-03-27 · proof |
| Cash and cash equivalents | $4.1 million | $12.7 million | -67.7% | 10-K 2024-03-27 · proof |
- What was Ampio Pharmaceuticals, Inc.'s net income in fiscal 2023?
- Ampio Pharmaceuticals, Inc. reported net income of -$8.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$16.3 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What was Ampio Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2023?
- Ampio Pharmaceuticals, Inc. reported cash from operating activities of -$8.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$21.1 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What are Ampio Pharmaceuticals, Inc.'s total assets?
- As of Dec 31, 2023, Ampio Pharmaceuticals, Inc. reported total assets of $5.7 million, against $13.6 million a year earlier (-57.8%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What are Ampio Pharmaceuticals, Inc.'s total liabilities?
- As of Dec 31, 2023, Ampio Pharmaceuticals, Inc. reported total liabilities of $2.4 million, against $1.8 million a year earlier (+32.1%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What are Ampio Pharmaceuticals, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Ampio Pharmaceuticals, Inc. reported cash and cash equivalents of $4.1 million, against $12.7 million a year earlier (-67.7%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1411906&period_type=annual&limit=5"Information only, not investment advice.